PL445252A1 - Mixture of compounds with appetite-reducing effect - Google Patents

Mixture of compounds with appetite-reducing effect

Info

Publication number
PL445252A1
PL445252A1 PL445252A PL44525223A PL445252A1 PL 445252 A1 PL445252 A1 PL 445252A1 PL 445252 A PL445252 A PL 445252A PL 44525223 A PL44525223 A PL 44525223A PL 445252 A1 PL445252 A1 PL 445252A1
Authority
PL
Poland
Prior art keywords
mixture
appetite
compounds
solution
reducing effect
Prior art date
Application number
PL445252A
Other languages
Polish (pl)
Inventor
Jacek Łyczko
Natalia Pachura
Marta Klemens
Michaela Godyla-Jabłoński
Kinga Adamenko
Antoni Szumny
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL445252A priority Critical patent/PL445252A1/en
Publication of PL445252A1 publication Critical patent/PL445252A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest mieszanina związków o działaniu redukującym apetyt, charakteryzująca się tym, że 100 ml zawiera 0,1 ml roztworu 2,5-dimetylopirazyny w bezwonnym rozpuszczalniku (1% w/w), 0,1 ml roztworu 2-etylo-3-metylopirazyny w bezwonnym rozpuszczalniku (1% w/w), 0,1 ml roztworu 2,6-dimetylopirazyny w bezwonnym rozpuszczalniku (100 mg/ml), 10 ml spożywczego aromatu kawa deserowa oraz 20 ml spożywczego aromatu czekoladowego. Mieszanina zawieszona jest w bezwonnym rozpuszczalniku o potwierdzonym statusie bezpieczeństwa i nietoksyczności.The subject of the application is a mixture of compounds with appetite-reducing action, characterized in that 100 ml contains 0.1 ml of a solution of 2,5-dimethylpyrazine in an odorless solvent (1% w/w), 0.1 ml of a solution of 2-ethyl-3-methylpyrazine in an odorless solvent (1% w/w), 0.1 ml of a solution of 2,6-dimethylpyrazine in an odorless solvent (100 mg/ml), 10 ml of a dessert coffee food aroma and 20 ml of a chocolate food aroma. The mixture is suspended in an odorless solvent with a confirmed safety and non-toxicity status.

PL445252A 2023-06-16 2023-06-16 Mixture of compounds with appetite-reducing effect PL445252A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445252A PL445252A1 (en) 2023-06-16 2023-06-16 Mixture of compounds with appetite-reducing effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445252A PL445252A1 (en) 2023-06-16 2023-06-16 Mixture of compounds with appetite-reducing effect

Publications (1)

Publication Number Publication Date
PL445252A1 true PL445252A1 (en) 2024-12-23

Family

ID=94644328

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445252A PL445252A1 (en) 2023-06-16 2023-06-16 Mixture of compounds with appetite-reducing effect

Country Status (1)

Country Link
PL (1) PL445252A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521427A (en) * 1983-05-17 1985-06-04 Nietupski Ronald S Appetite suppressant and method of application thereof
FR2727627A1 (en) * 1994-12-06 1996-06-07 Dukan Pierre Compsn. to reduce over-eating by smelling odoriferous substances
EP2143342A1 (en) * 2008-07-11 2010-01-13 Nestec S.A. Aroma compounds for weight management
US20100151066A1 (en) * 2007-06-05 2010-06-17 Merizzi Giulia Federica Composition for suppressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521427A (en) * 1983-05-17 1985-06-04 Nietupski Ronald S Appetite suppressant and method of application thereof
FR2727627A1 (en) * 1994-12-06 1996-06-07 Dukan Pierre Compsn. to reduce over-eating by smelling odoriferous substances
US20100151066A1 (en) * 2007-06-05 2010-06-17 Merizzi Giulia Federica Composition for suppressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect
EP2143342A1 (en) * 2008-07-11 2010-01-13 Nestec S.A. Aroma compounds for weight management

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
I. BATUBARA ET AL.: "Nutrients. 2015; 7(3): 1859-1870", EFFECTS OF INHALED CITRONELLA OIL AND RELATED COMPOUNDSON RAT BODY WEIGHT AND BROWN ADIPOSE TISSUE SYMPATHETIC NERVE. *
S.J. HONG ET AL.: "Nutrients. 2020; 12(7):2077", INHALATION OF PATCHOULI (POGOSTEMON CABLIN BENTH.) ESSENTIAL OIL IMPROVED METABOLIC PARAMETERS IN OBESITY-INDUCED SPRAGUE DAWLEY RATS. *

Similar Documents

Publication Publication Date Title
Yeh et al. Improvement in quality‐of‐life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double‐blind, placebo‐controlled study
US11357246B2 (en) High intensity sweeteners
US20150150303A1 (en) Electronic cigarette liquid and method of use to reduce, replace, or eliminate nicotine intake/addiction
EP4491199A3 (en) Gadolinium bearing pcta-based contrast agents
TR200101224T2 (en) Advanced tablet that quickly disintegrates.
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
MXPA04001256A (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof.
PT828728E (en) PHENYL DIHYDROBENZOFURANES
EA201890982A1 (en) IMPROVED LEVOSIMENDAN COMPOSITIONS FOR INTRAVENOUS INTRODUCTION IN THE FORM OF INFUSION OR INJECTION AND CONCENTRATE FOR INFUSION
MX2021005117A (en) Aerosolisable formulation.
PL445252A1 (en) Mixture of compounds with appetite-reducing effect
ECSP045349A (en) LIQUID FORMUILATIONS OF LOW DOSE TO ENTECAVIR AND USE
Rinehart et al. Postoperative global amnesia reversed with flumazenil
AR029900A1 (en) COMPOUNDS DERIVED FROM N- (HETEROCICLIL) BENZENE- OR PIRIDINSULFONAMIDE, PROCEDURE FOR THE PREPARATION AND MEDICINAL AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
PL445251A1 (en) Mixture of compounds with appetite stimulating effects
ITRM20030485A1 (en) COMPOSITION BASED ON CITICOLINE IN ASSOCIATION WITH VITAMINS FOR THE PREVENTION AND TREATMENT OF EYE PATOLGIES.
BR0014672A (en) Method for extending the aroma life of aqueous compositions flavored with aromas sensitive to moisture and acid, and aroma compositions that have extended aroma shelf lives
WO2020059808A8 (en) Sleep-improving agent
Gupta et al. Increasing use of flavoured tobacco products amongst youth
PL445248A1 (en) Mixture of compounds with appetite-reducing effect
PL445247A1 (en) Mixture of compounds with appetite-reducing effect
KR100869700B1 (en) Drowsiness mixture
Zailani et al. The Usage of E-Cigarette in Curbing Tobacco Addiction: A Baseline Study
Tadayon Oakland bans flavored tobacco products
US953947A (en) Remedy for swine-plague.